Menu

Latest news & events

Uyên Châu Nguyên wins UM Dissertation Prize 2025

Uyên Châu Nguyên wins UM Dissertation Prize 2025

29 January 2026

During the Dies Natalis of Maastricht University, Uyên Châu Nguyên received the UM Dissertation Prize 2025.

Read more
Global research network launched to study menopause and heart health

Global research network launched to study menopause and heart health

20 January 2026

Ten international health research funders, including the Dutch Heart Foundation, are investing $10 million in a new global research network to improve early prevention of cardiovascular disease in women. The initiative focuses on understanding how menopause affects heart health and how early intervention can reduce risk.

Read more
More newsMore events
Carim Maastricht
Carim Maastricht

Harry Crijns

Professor

Harry Crijns is professor and chair of Cardiology and board member of the Cardiovascular Research Institute Maastricht (CARIM) at Maastricht UMC+. He studied medicine at the University of Amsterdam and was trained in cardiology and electrophysiology in Groningen and Maastricht. He is a Fellow of the ESC and a past board member of the EHRA. He is also past Chair of the Netherlands Society of Cardiology. He served on several guidelines committees for the management of AF. Currently he is the chairman of the scientific advisory board of the Dutch Heart Foundation.

His primary research focus continues to be atrial fibrillation (AF). He founded the RACE trials in the Netherlands and led the Euro Heart Survey on AF (ESC). He has established his reputation by introducing innovative concepts for diagnosis and treatment of AF by showing that - quite contrary to longstanding beliefs - electrical management does not change prognosis. This revolutionised management of the arrhythmia worldwide with the effect that major interventions like electrical cardioversion, catheter ablation and antiarrhythmic drug therapy are applied in a much more personalized fashion.

Subsequently his group showed that rate control in AF can be individualized thereby removing the previously used strict heart rate targets from the international guidelines. He also performed the Euro Heart Survey on AF and made many contributions to the field of stroke management in AF, such as the construction of well-recognised AF specific risk stratification scores for AF progression (HATCH), ischemic stroke (CHA2DS2-VASc) and major bleeding (HAS-BLED). These scores have practically conquered the medical AF community and improved patient care whilst boosting new clinical research throughout the world.

His research group now focusses on recent-onset AF, hybrid AF ablation, upstream therapy and vascular mechanisms for AF progression and stroke in idiopathic atrial fibrillation. He is (co-)author on over 650 scientific articles, with 56,677 citations and Hirsch-index of 100.

Harry-crijns

Department of Cardiology
P. Debyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht


  • 2026
    • Cai, M., Barrios-Espinosa, C., Rienstra, M., Crijns, H. J. G. M., Schotten, U., & Heijman, J. (2026). Optimizing atrial fibrillation management using a novel patient-level computational model. Med, 7(1), Article 100896. https://doi.org/10.1016/j.medj.2025.100896
    • Svennberg, E., Freedman, B., Andrade, J. G., Anselmino, M., Biton, Y., Boriani, G., Brandes, A., Buckley, C. M., Cameron, A., Clua-Espuny, J. L., Crijns, H. J. G. M., Diederichsen, S. Z., Doehner, W., Dominguez, H., Duncker, D., Fauchier, L., Glotzer, T., Guo, Y. S., Haeusler, K. G., ... Et al. (2026). Recent-onset atrial fibrillation: challenges and opportunities. European Heart Journal, 47(2), 170-187. https://doi.org/10.1093/eurheartj/ehaf478
  • 2025
    • van de Kar, M. R. D., van Brakel, T. J., Houterman, S., de Heer, L. M., Daeter, E. J., van't Veer, M., van Veghel, D., Crijns, H. J. G. M., Dekker, L. R. C., Otterspoor, L. C., & Netherlands Heart Registration (2025). Real-world anticoagulant use and clinical outcomes in postoperative atrial fibrillation after coronary artery bypass grafting: a nationwide practice-based cohort from The Netherlands Heart Registration. European heart journal - Quality of care & clinical outcomes, Article qcaf124. Advance online publication. https://doi.org/10.1093/ehjqcco/qcaf124
    • Sohns, C., Moersdorf, M., Marrouche, N. F., Costard-Jaeckle, A., Crijns, H. J. G. M., Bergau, L., Fox, H., Hindricks, G., Dagres, N., Sossalla, S., Schramm, R., Fink, T., Hamriti, M. E., Sciacca, V., Didenko, M., Konietschke, F., Rudolph, V., Gummert, J., Tijssen, J. G. P., ... CASTLE HTx Investigators (2025). Three-Year Outcomes of Catheter Ablation in Patients With End-Stage Heart Failure and Atrial Fibrillation. Circulation, 152(15), 1118-1121. https://doi.org/10.1161/CIRCULATIONAHA.125.075787
    • Koolwijk, J., van de Kar, M., van der Woude, B. A., van 't Veer, M., de Grooth, H. J., Crijns, H. J. G. M., Dekker, L. R. C., Bouwman, R. A., Cremer, O. L., de Bie, A. J. R., & Otterspoor, L. C. (2025). Correction to: Anticoagulation and thromboembolic risk in critically ill patients with trigger-induced atrial fibrillation-A systematic review and meta-analysis. Netherlands Heart Journal, 33(10), 327-329. https://doi.org/10.1007/s12471-025-01991-y
    • Zeemering, S., Borof, K., Schotten, U., Obergassel, J., Camm, A. J., Crijns, H. J. G. M., Eckardt, L., Fabritz, L., Goette, A., Habibi, Z., Heijman, J., Hermans, B. J. M., Lemoine, M. D., Magnussen, C., Metzner, A., Rillig, A., Schnabel, R. B., Schuijt, E., Suling, A., ... Kirchhof, P. (2025). Estimated atrial fibrillation burden on early rhythm-control and cardiovascular events in the EAST-AFNET 4 trial. EClinicalMedicine, 88, Article 103457. https://doi.org/10.1016/j.eclinm.2025.103457
    • Goette, A., Lemoine, M. D., Borof, K., Schotten, U., Breithardt, G., Camm, A. J., Crijns, H. J. G. M., Eckardt, L., Metzner, A., Willems, S., Zapf, A., Schnabel, R. B., Fabritz, L., & Kirchhof, P. (2025). Prevalence and severity of atrial cardiomyopathy in patients with recently diagnosed atrial fibrillation and stroke risk factors and its association with early rhythm control: a secondary analysis of EAST-AFNET 4. EP Europace, 27(10), Article euaf256. https://doi.org/10.1093/europace/euaf256
    • Fink, T., Moersdorf, M., Costard-Jaeckle, A., Marrouche, N. F., Sciacca, V., Crijns, H. J. G. M., Fox, H., Hindricks, G., Dagres, N., Sossalla, S., Schramm, R., El Hamriti, M., Bergau, L., Didenko, M., Konietschke, F., Rudolph, V., Gummert, J., Tijssen, J. G. P., Sommer, P., ... CASTLE HTx Investigators (2025). Sex and Treatment Outcomes of Atrial Fibrillation Ablation in End-Stage Heart Failure: Insights From CASTLE-HTx. JACC: Heart Failure, 13(10), Article 102608. https://doi.org/10.1016/j.jchf.2025.102608
    • Obergassel, J., Suling, A., Borof, K., Camm, A. J., Crijns, H. J. G. M., Eckardt, L., Fabritz, L., Goette, A., Jensen, M., Lemoine, M. D., Magnussen, C., Metzner, A., Rillig, A., Schotten, U., Schnabel, R., Thomalla, G., Vardas, P., Wakili, R., Willems, S., ... Schrage, B. (2025). Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial. European Heart Journal, 46(37), 3663-3666. https://doi.org/10.1093/eurheartj/ehaf397
    • Koolwijk, J., van de Kar, M., van der Woude, B. A., van 't Veer, M., de Grooth, H.-J., Crijns, H. J. G. M., Dekker, L. R. C., Bouwman, R. A., Cremer, O. L., de Bie, A. J. R., & Otterspoor, L. C. (2025). Anticoagulation and thromboembolic risk in critically ill patients with trigger-induced atrial fibrillation-A systematic review and meta-analysis. Netherlands Heart Journal, 33(10), 290-298. https://doi.org/10.1007/s12471-025-01978-9
    • Frausing, M. H. J. P., Rienstra, M., Kronborg, M. B., De Melis, M., Schotten, U., Nielsen, J. C., Tieleman, R., Crijns, H. J. G. M., Van Gelder, I. C., & Samuel, M. (2025). Association between circulating biomarkers and atrial fibrillation burden in patients with paroxysmal atrial fibrillation: a subanalysis of the RACE V study. Open Heart, 12(2), Article e003433. https://doi.org/10.1136/openhrt-2025-003433
    • Metzner, A., Willems, S., Borof, K., Breithardt, G., Camm, A. J., Crijns, H. J. G. M., Eckardt, L., Fabritz, L., Gessler, N., Goette, A., Reissmann, B., Schnabel, R. B., Schotten, U., Zapf, A., Rillig, A., & Kirchhof, P. (2025). Diabetes and Obesity and Treatment Effect of Early Rhythm Control vs Usual Care in Patients With Atrial Fibrillation: A Secondary Analysis of the EAST-AFNET 4 Randomized Clinical Trial. JAMA Cardiology, 10(9), 932-941. https://doi.org/10.1001/jamacardio.2025.2374
    • Merino, J. L., Tamargo, J., Blomström-Lundqvist, C., Boriani, G., Crijns, H. J. G. M., Dobrev, D., Goette, A., Hohnloser, S. H., Naccarelli, G. V., Reiffel, J. A., Tfelt-Hansen, J., Martínez Cossiani, M., & Camm, A. J. (2025). Practical Compendium of Antiarrhythmic Drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology. EP Europace, 27(8), Article euaf076. https://doi.org/10.1093/europace/euaf076
    • Velt, M. J. H., van Gelder, I. C., Crijns, H. J. G. M., Rienstra, M., & Mulder, B. A. (2025). Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study. International Journal of Cardiology, 439, Article 133669. https://doi.org/10.1016/j.ijcard.2025.133669
    • Hengstman, G., Said, S. A. M., de Nooijer, R., Voorhorst, P. J. M., van der Holst, F. H. J., Kamphuis-Wolters, F. F., Van Gelder, I. C., & Crijns, H. J. G. M. (2025). NuRse-led home CardiovErsion for control of atrial fibrillation-RACE 6. Netherlands Heart Journal, 33(9), 281-285. https://doi.org/10.1007/s12471-025-01972-1
    • Rottner, L., Lemoine, M. D., Eckardt, L., Borof, K., Camm, A. J., Goette, A., Breithardt, G., Metzner, A., Schotten, U., Zapf, A., Heidbuechel, H., Willems, S., Crijns, H., Schnabel, R. B., Fabritz, L., Magnussen, C., Rillig, A., & Kirchhof, P. (2025). Safety and efficacy of amiodarone and dronedarone for early rhythm control in EAST-AFNET 4. Clinical research in cardiology, Article e011585. https://doi.org/10.1007/s00392-025-02637-0
    • Sohns, C., Fink, T., Crijns, H. J. G. M., Costard-Jaeckle, A., Marrouche, N. F., Sossalla, S., Schramm, R., El Hamriti, M., Moersdorf, M., Didenko, M., Braun, M., Sciacca, V., Konietschke, F., Rudolph, V., Gummert, J., Tijssen, J. G. P., Sommer, P., & CASTLE-VTInvestigators (2025). Preventive catheter ablation for ventricular arrhythmias in patients with end-stage heart failure referred for heart transplantation evaluation: Rationale for and design of the CASTLE-VT trial. European journal of heart failure, 27(4), 690-696. https://doi.org/10.1002/ejhf.3512
    • Kirchhof, P., Camm, A. J., Crijns, H. J. G. M., Piccini, J. P., Torp-Pedersen, C., McKindley, D. S., Wieloch, M., & Hohnloser, S. H. (2025). Dronedarone provides effective early rhythm control: post-hoc analysis of the ATHENA trial using EAST-AFNET 4 criteria. EP Europace, 27(4), Article euaf080 . https://doi.org/10.1093/europace/euaf080
    • Sohns, C., Marrouche, N. F., Crijns, H. J. G. M., Sossalla, S., Sciacca, V., Tijssen, J. G. P., Sommer, P., & CASTLE HTx Investigators (2025). In Castle-Htx Trial We Trust. Journal of the American College of Cardiology, 85(11), 1207-1209. https://doi.org/10.1016/j.jacc.2024.10.092
    • Roselli, C., Surakka, I., Olesen, M. S., Sveinbjornsson, G., Marston, N. A., Choi, S. H., Holm, H., Chaffin, M., Gudbjartsson, D., Hill, M. C., Aegisdottir, H., Albert, C. M., Alonso, A., Anderson, C. D., Arking, D. E., Arnar, D. O., Barnard, J., Benjamin, E. J., Braunwald, E., ... Ellinor, P. T. (2025). Meta-analysis of genome-wide associations and polygenic risk prediction for atrial fibrillation in more than 180,000 cases. Nature Genetics, 57(3), 539-547. Article 11303. https://doi.org/10.1038/s41588-024-02072-3
    • van Deutekom, C., van de Lande, M. E., Rama, R., Nguyen, B.-O., Tieleman, R. G., Weberndoerfer, V., Hemels, M. E. W., de Melis, M., Schotten, U., Linz, D., Crijns, H. J. G. M., van Gelder, I. C., & Rienstra, M. (2025). Multimorbidity Is Associated With Symptom Severity and Disease Progression in Patients with Paroxysmal Atrial Fibrillation-Data From the RACE V Study. Journal of the American Heart Association, 14(5), Article e034514. https://doi.org/10.1161/JAHA.123.034514
    • van Mourik, M. J. W., Keijsers, L., van der Velden, R. M. J., Vorstermans, B., Crijns, H. J. G. M., Muris, J. W. M., Linz, D. K., & Gidding-Slok, A. (2025). Patients perspectives on integrating eHealth in regular care pathways for atrial fibrillation: evaluating photoplethysmography for remote self-assessment. European Journal of Cardiovascular Nursing, 24(2), 305-313. https://doi.org/10.1093/eurjcn/zvae156
    • Isaacs, A., Zeemering, S., Winters, J., Batlle, M., Bidar, E., Boukens, B., Casadei, B., Chua, W., Crijns, H. J. G. M., Fabritz, L., Guasch, E., Hatem, S. N., Hermans, B., Kääb, S., Kawczynski, M., Maesen, B., Maessen, J., Mont, L., Sinner, M. F., ... Stoll, M. (2025). Lateral Atrial Expression Patterns Provide Insights into Local Transcription Disequilibrium Contributing to Disease Susceptibility. Circulation: Genomic and Precision Medicine, 18(1), Article e004594. https://doi.org/10.1161/CIRCGEN.124.004594
    • Sciacca, V., Sohns, C., Crijns, H. J. G. M., Marrouche, N. F., Schramm, R., Moersdorf, M., Fink, T., Bergau, L., Hindricks, G., Dagres, N., Sossalla, S., Costard-Jaeckle, A., Fox, H., El Hamriti, M., Konietschke, F., Rudolph, V., Gummert, J., Tijssen, J. G. P., Sommer, P., & CASTLE HTx Investigators (2025). Effects of atrial fibrillation ablation on arrhythmia burden and ventricular function in end-stage heart failure: Lessons from CASTLE-HTx. European journal of heart failure, 27(2), 255-263. https://doi.org/10.1002/ejhf.3505
    • Spoormans, E. M., Thevathasan, T., Van Royen, N., Zwinderman, A. H., Freund, A., Thiele, H., Ziesemer, K., Desch, S., Lemkes, J. S., Janssens, G. N., van der Hoeven, N. W., Jewbali, L. S. D., Dubois, E. A., Meuwissen, M., Rijpstra, T. A., Bosker, H. A., Blans, M. J., Bleeker, G. B., Baak, R., ... COACT and TOMAHAWK Trials Investigators (2025). One-Year Outcomes of Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST Elevation: An Individual Patient Data Meta-Analysis. JAMA Cardiology, 10(8), 779-786. https://doi.org/10.1001/jamacardio.2025.1194
  • 2024
    • Rienstra, M., Tzeis, S., Bunting, K., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Sanders, P., Svennberg, E., Casado-Arroyo, R., Dwight, J., Guasti, L., Hanke, T., Jaarsma, T., Lettino, M., Lochen, M.-L., Lumbers, R. T., Maesen, B., Molgaard, I., Rosano, G. M. C., ... Van Gelder, I. C. (2024). Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects. EP Europace, 26(12), Article euae298. https://doi.org/10.1093/europace/euae298
    • Velt, M. J. H., Crijns, H. J. G. M., van Gelder, I. C., Linz, D., van de Lande, M. E., Ten Cate, H., Spronk, H. M. H., de Melis, M., Rienstra, M., & Mulder, B. A. (2024). Dynamic biomarker profiles in patients with paroxysmal atrial fibrillation: Assessing the differences between sinus rhythm and acute atrial fibrillation episode. International Journal of Cardiology, 417, Article 132526. https://doi.org/10.1016/j.ijcard.2024.132526
    • Fabritz, L., Al-Taie, C., Borof, K., Breithardt, G., Camm, A. J., Crijns, H. J. G. M., Roth Cardoso, V., Chua, W., van Elferen, S., Eckardt, L., Gkoutos, G., Goette, A., Guasch, E., Hatem, S., Metzner, A., Mont, L., Murukutla, V. A., Obergassel, J., Rillig, A., ... Kirchhof, P. (2024). Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study. European Heart Journal, 45(47), 5002-5019. https://doi.org/10.1093/eurheartj/ehae611
    • Sohns, C., Moersdorf, M., Marrouche, N. F., Bergau, L., Costard-Jaeckle, A., Crijns, H. J. G. M., Fox, H., Hindricks, G., Dagres, N., Sossalla, S., Schramm, R., Fink, T., El Hamriti, M., Sciacca, V., Didenko, M., Konietschke, F., Rudolph, V., Gummert, J., Tijssen, J. G. P., ... CASTLE HTx Investigators (2024). Catheter Ablation in Patients with End-Stage Heart Failure and Atrial Fibrillation: Two-year Follow-up of the CASTLE-HTx Trial. Circulation, 150(23), 1904-1906. https://doi.org/10.1161/CIRCULATIONAHA.124.071517
    • van Veldhuisen, D. J., Rienstra, M., Mosterd, A., Alings, A. M., van Asselt, A. D. J., Bouvy, M. L., Tijssen, J. G. P., Schaap, J., van der Wall, E. E., Voors, A. A., Boorsma, E. M., Lok, D. J. A., Crijns, H. J. G. M., Schut, A., Vijver, M. A. T., Voordes, G. H. D., de Vos, A. H., Maas-Soer, E. L., Smit, N. W., ... DECISION Investigators & Commitees (2024). Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial. European journal of heart failure, 26(10), 2223-2230. https://doi.org/10.1002/ejhf.3428
    • Champsi, A., Mobley, A. R., Subramanian, A., Nirantharakumar, K., Wang, X., Shukla, D., Bunting, K., Molgaard, I., Dwight, J., Casado Arroyo, R., Crijns, H. J. G. M., Guasti, L., Lettino, M., Lumbers, R. T., Maesen, B., Rienstra, M., Svennberg, E., Tica, O., Traykov, V., ... Kotecha, D. (2024). Gender and contemporary risk of adverse events in atrial fibrillation. European Heart Journal, 45(36), 3707-3717. Article ehae539. https://doi.org/10.1093/eurheartj/ehae539
    • Van Gelder, I. C., Kotecha, D., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., Jaarsma, T., Lettino, M., Løchen, M. L., Lumbers, R. T., Maesen, B., Mølgaard, I., Rosano, G. M. C., Sanders, P., ... ESC Scientific Document Group (2024). 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 45(36), 3314-3414. https://doi.org/10.1093/eurheartj/ehae176
    • van de Kar, M. R. D., van Brakel, T. J., Van't Veer, M., van Steenbergen, G. J., Daeter, E. J., Crijns, H. J. G. M., van Veghel, D., Dekker, L. R. C., & Otterspoor, L. C. (2024). Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis. European Heart Journal, 45(29), 2620-2630. https://doi.org/10.1093/eurheartj/ehae267
    • Sanders, P., Svennberg, E., Diederichsen, S. Z., Crijns, H. J. G. M., Lambiase, P. D., Boriani, G., & Van Gelder, I. C. (2024). Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation. European Heart Journal, 45(29), 2594-2603. https://doi.org/10.1093/eurheartj/ehae365
    • Lenting, C. J., Wijtvliet, E. P. J. P., Koldenhof, T., Bessem, B., Pluymaekers, N. A. H. A., Rienstra, M., Folkeringa, R. J., Bronzwaer, P., Elvan, A., Elders, J., Tukkie, R., Luermans, J. G. L. M., Van Kuijk, S. M. J., Tijssen, J. G. P., Van Gelder, I. C., Crijns, H. J. G. M., & Tieleman, R. G. (2024). Previous Exercise Levels and Outcome in Patients with New Atrial Fibrillation: 'Past Achievements Do Not Predict the Future'. Medicine and Science in Sports and Exercise, 56(8), 1349-1354. https://doi.org/10.1249/MSS.0000000000003424
    • Moersdorf, M., Tijssen, J. G. P., Marrouche, N. F., Crijns, H. J. G. M., Costard-Jaeckle, A., Bergau, L., Hindricks, G., Dagres, N., Sossalla, S., Schramm, R., Fox, H., Fink, T., El Hamriti, M., Sciacca, V., Konietschke, F., Rudolph, V., Gummert, J., Sommer, P., Sohns, C., & CASTLE HTx Investigators (2024). Prognosis of patients in end-stage heart failure with atrial fibrillation treated with ablation - Insights from Castle HTX. Heart Rhythm, 21(7), 1008-1015. https://doi.org/10.1016/j.hrthm.2024.04.013
    • Rillig, A., Eckardt, L., Borof, K., Camm, A. J., Crijns, H. J. G. M., Goette, A., Breithardt, G., Lemoine, M. D., Metzner, A., Rottner, L., Schotten, U., Vettorazzi, E., Wegscheider, K., Zapf, A., Heidbuchel, H., Willems, S., Fabritz, L., Schnabel, R. B., Magnussen, C., & Kirchhof, P. (2024). Safety and efficacy of long-term Sodium Channel Blocker therapy for Early Rhythm Control: The EAST-AFNET 4 trial. EP Europace, 26(6), Article euae121. https://doi.org/10.1093/europace/euae121
    • Ruskin, J. N., Camm, A. J., Dufton, C., Woite-Silva, A. C., Tuininga, Y., Badings, E., De Jong, J. S. S. G., Oosterhof, T., Aksoy, I., Kuijper, A. F. M., Van Gelder, I. C., van Dijk, V., Nuyens, D., Schellings, D., Lee, M. Y., Kowey, P. R., Crijns, H. J. G. M., Maupas, J., Belardinelli, L., & INSTANT Investigators (2024). Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial. JACC: Clinical Electrophysiology, 10(6), 1021-1033. https://doi.org/10.1016/j.jacep.2024.02.021
    • Crijns, H. J. G. M., Lambiase, P. D., & Sanders, P. (2024). The year in cardiovascular medicine 2023: the top 10 papers in arrhythmias. European Heart Journal, 45(19), 1730-1732. https://doi.org/10.1093/eurheartj/ehae189
    • van der Velden, R. M. J., Bonander, C., Crijns, H. J. G. M., Kemp-Gudmundsdottir, K., Engdahl, J., Linz, D., & Svennberg, E. (2024). Adherence to a handheld device-based atrial fibrillation screening protocol is associated with clinical outcomes. Heart, 110(9), 626-634. https://doi.org/10.1136/heartjnl-2023-323522
    • Fabritz, L., Chua, W., Cardoso, V. R., Al-Taie, C., Borof, K., Suling, A., Krause, L., Kany, S., Magnussen, C., Wegscheider, K., Breithardt, G., Crijns, H. J. G. M., Camm, A. J., Gkoutos, G., Ellinor, P. T., Goette, A., Schotten, U., Wienhues-Thelen, U.-H., Zeller, T., ... Kirchhof, P. (2024). Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study. Cardiovascular Research, 120(8), 855-868. https://doi.org/10.1093/cvr/cvae067
    • Spoormans, E. M., Lemkes, J. S., Janssens, G. N., van der Hoeven, N. W., Jewbali, L. S. D., Dubois, E. A., Meuwissen, M., Rijpstra, T. A., Bosker, H. A., Blans, M. J., Bleeker, G. B., Baak, R., Vlachojannis, G. J., Eikemans, B. J. W., van der Harst, P., van der Horst, I. C. C., Voskuil, M., van der Heijden, J. J., Beishuizen, A., ... van Royen, N. (2024). The Prognostic Value of Troponin-T in Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation: A COACT Substudy. Journal of the Society for Cardiovascular Angiography and Interventions, 3(2), Article 101191. https://doi.org/10.1016/j.jscai.2023.101191
    • van der Velden, R. M. J., Pluymaekers, N. A. H. A., Dudink, E. A. M. P., Luermans, J. G. L. M., Meeder, J. G., Heesen, W. F., Lenderink, T., Widdershoven, J. W. M. G., Bucx, J. J. J., Rienstra, M., Kamp, O., van Opstal, J. M., Kirchhof, C. J. H. J., van Dijk, V. F., Swart, H. P., Alings, M., Van Gelder, I. C., Crijns, H. J. G. M., & Linz, D. (2024). Cardioversion strategy impacts rate control during recurrences in patients with paroxysmal atrial fibrillation: A subanalysis of the RACE 7 ACWAS trial. Clinical Cardiology, 47(1), Article e24161. https://doi.org/10.1002/clc.24161
    • Frausing, M. H. J. P., van de Lande, M., Linz, D., Crijns, H. J. G. M., Tieleman, R. G., Hemels, M. E. W., De Melis, M., Schotten, U., Kronborg, M. B., Nielsen, J. C., Van Gelder, I., & Rienstra, M. (2024). Healthcare utilisation and quality of life according to atrial fibrillation burden, episode frequency and duration. Heart, 110(16), 1030-1039. https://doi.org/10.1136/heartjnl-2024-324016
  • 2023
    • Mulder, B. A., Khalilian Ekrami, N., Van De Lande, M. E., Nguyen, B.-O., Weberndorfer, V., Crijns, H. J., Geelhoed, B., Blaauw, Y., Hemels, M. E., Tieleman, R. G., Scheerder, C. O., De Melis, M., Schotten, U., Linz, D., Van Gelder, I. C., & Rienstra, M. (2023). Women have less progression of paroxysmal atrial fibrillation: data from the RACE V study. Open Heart, 10(2), Article e002534. https://doi.org/10.1136/openhrt-2023-002534
    • Chua, W., Cardoso, V. R., Guasch, E., Sinner, M. F., Al-Taie, C., Brady, P., Casadei, B., Crijns, H. J. G. M., Dudink, E. A. M. P., Hatem, S. N., Kääb, S., Kastner, P., Mont, L., Nehaj, F., Purmah, Y., Reyat, J. S., Schotten, U., Sommerfeld, L. C., Zeemering, S., ... Fabritz, L. (2023). An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions. Scientific Reports, 13(1), Article 16743. https://doi.org/10.1038/s41598-023-42331-7
    • Frausing, M. H. J. P., van de Lande, M. E., Maass, A. H., Nguyen, B. O., Hemels, M. E. W., Tieleman, R. G., Koldenhof, T., De Melis, M., Linz, D., Schotten, U., Weberndoerfer, V., Crijns, H. J. G. M., Van Gelder, I. C., Nielsen, J. C., & Rienstra, M. (2023). Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation. Heart, 109(17), 1286-1293. https://doi.org/10.1136/heartjnl-2022-322253
    • van Mourik, M. J. W., Linz, D., Verwijs, H. J. A., Bekkers, S. C. A. M., Weerts, J., Schotten, U., Rocca, H. B.-L., Lumens, J., Crijns, H. J. G. M., Weijs, B., & Knackstedt, C. (2023). Evaluating subclinical left ventricular and left atrial dysfunction in idiopathic atrial fibrillation: A speckle-tracking based strain-analysis. International Journal of Cardiology, 383(1), 159-165. https://doi.org/10.1016/j.ijcard.2023.04.024
    • van der Heijden, C. A. J., Weberndörfer, V., Vroomen, M., Luermans, J. G., Chaldoupi, S. M., Bidar, E., Vernooy, K., Maessen, J. G., Pison, L., van Kuijk, S. M. J., La Meir, M., Crijns, H. J. G. M., & Maesen, B. (2023). Hybrid Ablation Versus Repeated Catheter Ablation in Persistent Atrial Fibrillation: A Randomized Controlled Trial. JACC: Clinical Electrophysiology, 9(7), 1013-1023. https://doi.org/10.1016/j.jacep.2022.12.011
    • Koldenhof, T., Van Gelder, I. C., Crijns, H. J. G. M., Rienstra, M., & Tieleman, R. G. (2023). Rate control in atrial fibrillation, calcium channel blockers versus beta-blockers. Heart, 109(23), 1759 - 1764. https://doi.org/10.1136/heartjnl-2023-322635
Overview